Research Supports OmniActive’s Capsimax as a GLP-1 ‘Booster’

Research Supports OmniActive’s Capsimax as a GLP-1 ‘Booster’

NutraIngredients (EU)
NutraIngredients (EU)Apr 24, 2026

Why It Matters

Elevated GLP‑1 links to better appetite control and metabolic health, giving supplement brands a scientifically backed edge in the fast‑growing weight‑loss and performance sectors. The study’s performance gains also suggest a competitive advantage for athletes seeking natural, tolerable ergogenic aids.

Key Takeaways

  • Capsimax raised GLP‑1 by 13% after seven days
  • Study showed significant gains in peak force and power
  • Resting energy expenditure increased alongside improved muscular endurance
  • Non‑stimulant, low‑dose format avoids harsh capsaicin side effects

Pulse Analysis

The surge in consumer interest around glucagon‑like peptide‑1 (GLP‑1) has extended beyond pharmaceuticals into the supplement arena, where brands are scrambling for ingredients that can naturally stimulate this hormone. Capsimax, a standardized Capsicum annuum extract, joins a short list of botanicals with peer‑reviewed data showing a measurable GLP‑1 lift. By delivering a modest 13% increase without the gastrointestinal discomfort associated with synthetic GLP‑1 agonists, the ingredient offers a pathway for weight‑management products to claim metabolic support backed by clinical evidence.

The Indian study published in the Academic Journal of Sports Science & Medicine employed a rigorous double‑blind, crossover design, testing 100 mg of Capsimax over seven days in trained men. Participants not only experienced higher GLP‑1 but also recorded gains in peak force, rate of force development, and both peak and average power during resistance exercises. Resting energy expenditure rose, indicating a thermogenic effect that complements the extract’s known lipolytic properties. Importantly, the trial documented reduced fatigue and improved muscular endurance, suggesting that Capsimax can enhance performance while supporting recovery through its antioxidant polyphenols and terpenoids.

For supplement manufacturers, these results unlock a dual‑benefit narrative: metabolic health and athletic performance from a single, low‑dose botanical. The non‑stimulant profile sidesteps the sensory irritation that has limited broader adoption of traditional capsaicin, making Capsimax suitable for daily use in functional foods, sports drinks, and weight‑loss formulas. As regulators and consumers alike demand more transparent, evidence‑based claims, OmniActive’s data positions Capsimax to become a cornerstone ingredient in next‑generation wellness and performance portfolios, while prompting further research into long‑term GLP‑1 modulation through plant‑derived compounds.

Research supports OmniActive’s Capsimax as a GLP-1 ‘booster’

Comments

Want to join the conversation?

Loading comments...